Is $KPTI pump-proof?

Karyopharm Therapeutics Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-10-30.

$KPTI
Karyopharm Therapeutics Inc.
ELEVATED RISK
59
/ 100 trap score
The move is real but the structure is the problem: an active dilution setup, and it's already up +28% in five sessions.
Hype / crowding
55
Run-up / extension
32
Structural risk
95
$Effective shelf (S-3): declared effective 6 months ago; live permission to issue new shares "from time to time" [S-3 2026-05-04]↗
🔒 6 more filings flagged on $KPTI: see all of them free.
All 7 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-10-30 · not financial advice

The record on $KPTI

first scored Oct 28: -20% since
57Oct 28
69Oct 29
59Oct 30
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What a shelf registration is →What a going-concern warning means →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.